Latest Biopharmaceuticals Podcast Episodes
Karine Rossignol: Co-Founder and CEO of Smart Immune
BioBoss - May 21, 2024 16:00 - 35 minutes ★★★★★ - 7 ratingsKarine Rossignol, co-founder and CEO of Smart Immune, shares her insights with BioBoss host John Simboli about leadership in biopharma and how Smart Immune is working to harness a patient's own thymus to re-arm the immune system against cancer and infection.
Listener takeover: Your Biotech Questions Answered
I AM BIO - May 07, 2024 09:00 - 21 minutes ★★★★★ - 67 ratingsYOU asked, and we answered. In this episode, we had our experts on standby to answer questions from you, our listeners. We discuss topics ranging from the safety of genetically modified foods (GMOs), to the new era of personalized medicine, feeding the world by 2050, and even what makes start-up...
Editing Cells Within the Body—a New CRISPR Frontier
I AM BIO - April 23, 2024 09:00 - 21 minutes ★★★★★ - 67 ratingsWith its potential to expand the horizons of what’s possible for patients, CRISPR is the new darling of biotech. Reaching an important milestone in 2023 with the FDA approval of a sickle cell treatment using CRISPR, the technology is poised to break new barriers for treating patients in the near...
Erik Buntinx: Founder and CEO of ANeuroTech
BioBoss - April 20, 2024 17:00 - 49 minutes ★★★★★ - 7 ratingsErik Buntinx, founder and CEO of ANeuroTech, shares his thoughts with BioBoss host John Simboli about leadership in biopharma and how ANeurotech is working to develop effective treatments, with minimal or no side-effects, for patients who suffer with depression
Biotech is Climate Tech
I AM BIO - April 09, 2024 09:00 - 21 minutes ★★★★★ - 67 ratingsBiotech companies are addressing climate change through innovation—from carbon neutral facilities to agricultural innovations to reduce greenhouse gas emissions. BIO was on the ground at the COP28 UN Climate Change Conference in Dubai to deliver the message that biotech is climate tech. Follow ...
Biotech for our Pets
I AM BIO - March 26, 2024 09:00 - 28 minutes ★★★★★ - 67 ratingsMore than half of U.S. households include pets, but there has been a lack of medical treatments developed specifically for small animals. Biotech companies are working to change that with new treatment options that both borrow from and, potentially, advance human health discoveries. Follow us o...
Helen Torley: CEO of Halozyme Therapeutics
BioBoss - March 25, 2024 14:00 - 39 minutes ★★★★★ - 7 ratingsHelen Torley, CEO of Halozyme Therapeutics, shares her thoughts with BioBoss host John Simboli about leadership in biopharma and how Halozyme is working to reinvent the patient experience by easing the burden of treatment and improving patient outcomes.
What We Know About the Microbiome
I AM BIO - March 12, 2024 09:00 - 27 minutes ★★★★★ - 67 ratingsThe gut microbiome, which consists of trillions of bacteria, viruses, and fungi, plays a crucial role in our health. However, there is still much to learn about this complex ecosystem. On this episode we talk with experts who tell us where the science is—how much we know, and how much we don’t. ...
Is CRISPR the New Sickle Cell Savior?
I AM BIO - February 27, 2024 10:00 - 24 minutes ★★★★★ - 67 ratings2023 ended with an exciting biotech breakthrough for sickle cell patients. A gene-editing therapy using the revolutionary CRISPR technology provides new hope and options for the nearly 100,000 Americans with sickle cell disease. In this episode, we talk with the company behind one of the life-ch...
James Graham: CEO of Recce Pharmaceuticals
BioBoss - February 24, 2024 17:00 - 21 minutes ★★★★★ - 7 ratingsJames Graham, CEO of Recce Pharmaceuticals, shares his thoughts with BioBoss host John Simboli about leadership in biopharma and how Recce is working to develop a new class of synthetic anti-infectives designed to address the threat of antibiotic-resistant superbugs.
“On My Own”—Desperate to Stop a Resistant Bacterial Infection (REDUX)
I AM BIO - February 06, 2024 10:00 - 27 minutes ★★★★★ - 67 ratingsBradley Burnam woke up one morning, looked in the mirror and found one ear twice it’s normal size and his face swollen and discolored. He would spend the next several years in and out of the hospital fighting a relentless infection that would not respond to available treatments. The experience t...
Mike Gaffney: CEO of Cellphire Therapeutics
BioBoss - January 27, 2024 17:00 - 39 minutes ★★★★★ - 7 ratingsMike Gaffney, CEO of Cellphire Therapeutics, shares his thoughts with BioBoss host John Simboli about leadership in biopharma and how Cellphire is working to save lives by bringing novel hemostatic products to patients in need.
The Synbio Revolution is Here (REDUX)
I AM BIO - January 23, 2024 10:00 - 26 minutes ★★★★★ - 67 ratingsInnovative companies are using synthetic biology to engineer organisms and create new materials that could transform every sector of our economy, from health care to food and energy production. Those companies say we’ve entered a synbio revolution, and it holds potential to improve the health of...
How Biotechs Survive the Valley of Death (REDUX)
I AM BIO - January 10, 2024 10:00 - 25 minutes ★★★★★ - 67 ratingsFor biotech companies, the valley of death describes the difficult path from initial discovery to FDA approval and commercialization. It's a treacherous journey—one that even promising innovations often don't complete. Adequate funding, regulatory hurdles and the immense complexity of the biotec...
Biotech Women Striking at the Glass Ceiling (REDUX)
I AM BIO - December 26, 2023 10:00 - 24 minutes ★★★★★ - 67 ratingsThe biotech industry offers unique opportunities for women to advance as executives and entrepreneurs. There are headwinds, however, including unequal access to venture capital. In this episode, we talk with three executives who are part of a wave of women-led companies in biotech. Our guests sp...
#66 - David Baram: founder and CEO of EmendoBio
BioBoss - December 16, 2023 17:00 - 35 minutes ★★★★★ - 7 ratingsDavid Barmam, founder and CEO of Emendio Biotherapeutics, shares his thoughts with BioBoss host John Simboli about leadership in biopharma and how Emendo is working to evolve traditional CRISPR tools and create new nucleases customized to any genetic disease.
David Baram: Founder and CEO of EmendoBio
BioBoss - December 16, 2023 17:00 - 35 minutes ★★★★★ - 7 ratingsDavid Barmam, founder and CEO of Emendio Biotherapeutics, shares his thoughts with BioBoss host John Simboli about leadership in biopharma and how Emendo is working to evolve traditional CRISPR tools and create new nucleases customized to any genetic disease.
Welcome to Season 6 of BioBoss
BioBoss - December 15, 2023 01:00 - 44 seconds ★★★★★ - 7 ratingsBioBoss podcast host John Simboli reflects on Seasons 1-5 and invites listeners to Season 6 starting in January 2024
We Need Bees. Bees Need Biotech. (REDUX)
I AM BIO - December 12, 2023 10:00 - 26 minutes ★★★★★ - 67 ratingsBees and other pollinators are critical to our survival, with one out of every three bites of food we eat depending on pollination to produce. That’s why reports of a decline in bee populations and rising threats from pests, viruses and environmental pressures, including climate change, are alar...
The Horseshoe Crab Saved Us. Can We Save the Horseshoe Crab? (REDUX)
I AM BIO - November 28, 2023 10:00 - 28 minutes ★★★★★ - 67 ratingsThe horseshoe crab has endured for over 450 million years. It has survived several mass extinctions including the one that killed off the dinosaurs. One reason for their incredible resiliency is their ability to fend off bacterial infection. Their blood contains cells that clot around invading b...
“On My Own”—Desperate to Stop a Resistant Bacterial Infection
I AM BIO - November 14, 2023 10:00 - 27 minutes ★★★★★ - 67 ratingsBradley Burnam woke up one morning, looked in the mirror and found one ear twice it’s normal size and his face swollen and discolored. He would spend the next several years in and out of the hospital fighting a relentless infection that would not respond to available treatments. The experience t...
#65 - Anat Binur: co-founder & CEO of Ukko
BioBoss - November 07, 2023 15:00 - 35 minutes ★★★★★ - 7 ratingsAnat Binur, co-founder and CEO of Ukko, shares her thoughts with BioBoss host John Simboli about leadership in biopharma and how Ukko is working to improve the lives of people who suffer from food allergies.
Anat Binur: Co-Founder and CEO of Ukko
BioBoss - November 07, 2023 15:00 - 35 minutes ★★★★★ - 7 ratingsAnat Binur, co-founder and CEO of Ukko, shares her thoughts with BioBoss host John Simboli about leadership in biopharma and how Ukko is working to improve the lives of people who suffer from food allergies.
The Synbio Revolution is Here
I AM BIO - October 31, 2023 09:00 - 26 minutes ★★★★★ - 67 ratingsFollow us on LinkedIn, X, Facebook and Instagram. Visit us at https://www.bio.org/ Innovative companies are using synthetic biology to engineer organisms and create new materials that could transform every sector of our economy, from health care to food and energy production. Those companies ...
How Biotechs Survive the Valley of Death
I AM BIO - October 17, 2023 09:00 - 25 minutes ★★★★★ - 67 ratingsFollow us on LinkedIn, X, Facebook and Instagram. Visit us at https://www.bio.org/ For biotech companies, the valley of death describes the difficult path from initial discovery to FDA approval and commercialization. It's a treacherous journey—one that even promising innovations often don't c...
#64 - Markku Jalkanen: founder & CEO, Faron Pharmaceuticals
BioBoss - October 06, 2023 12:00 - 27 minutes ★★★★★ - 7 ratingsMarkku Jalkanen, founder and CEO of Faron Pharmaceuticals, shares his thoughts with BioBoss host John Simboli about leadership in biopharma and how Faron is working to develop new immunotherapies to address unmet medical needs in cancer and improve patient lives.
Markku Jalkanen: Founder and CEO of Faron Pharmaceuticals
BioBoss - October 06, 2023 12:00 - 27 minutes ★★★★★ - 7 ratingsMarkku Jalkanen, founder and CEO of Faron Pharmaceuticals, shares his thoughts with BioBoss host John Simboli about leadership in biopharma and how Faron is working to develop new immunotherapies to address unmet medical needs in cancer and improve patient lives.
Biotech Women Striking at the Glass Ceiling
I AM BIO - October 03, 2023 09:00 - 24 minutes ★★★★★ - 67 ratingsFollow us on LinkedIn, X, Facebook and Instagram. Visit us at https://www.bio.org/ The biotech industry offers unique opportunities for women to advance as executives and entrepreneurs. There are headwinds, however, including unequal access to venture capital. In this episode, we talk with th...
We Need Bees. Bees Need Biotech.
I AM BIO - September 19, 2023 09:00 - 26 minutes ★★★★★ - 67 ratingsFollow us on LinkedIn, X, Facebook and Instagram. Visit us at https://www.bio.org/ Bees and other pollinators are critical to our survival, with one out of every three bites of food we eat depending on pollination to produce. That’s why reports of a decline in bee populations and rising threa...
Lisa Deschamps: CEO of AviadoBio
BioBoss - September 11, 2023 16:00 - 46 minutes ★★★★★ - 7 ratingsLisa Deschamps, CEO of AviadoBio, shares her thoughts with BioBoss host John Simboli about leadership in biopharma and how AviadoBio is working to develop transformative medicines for patients living with debilitating and life-threatening neurodegenerative disorders.
Related Biopharmaceuticals Topics
- Biotechnology 2
- Biotech 2